Experimental Hematology
Volume 35, Issue 3 , Pages 416-425, March 2007

Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25 T lymphocytes

  • Emilie Brillard

      Affiliations

    • INSERM U645, University of Franche Comté, EFS Bourgogne Franche Comté, Besançon, France
    • Drs. Brillard and Pallandre contributed equally to this study.
  • ,
  • Jean-René Pallandre

      Affiliations

    • INSERM U645, University of Franche Comté, EFS Bourgogne Franche Comté, Besançon, France
    • Drs. Brillard and Pallandre contributed equally to this study.
  • ,
  • David Chalmers

      Affiliations

    • INSERM U645, University of Franche Comté, EFS Bourgogne Franche Comté, Besançon, France
  • ,
  • Bernhard Ryffel

      Affiliations

    • GEM2358, CNRS, Orléans, France
  • ,
  • Amandine Radlovic

      Affiliations

    • INSERM U645, University of Franche Comté, EFS Bourgogne Franche Comté, Besançon, France
  • ,
  • Estelle Seilles

      Affiliations

    • INSERM U645, University of Franche Comté, EFS Bourgogne Franche Comté, Besançon, France
  • ,
  • Pierre Simon Rohrlich

      Affiliations

    • INSERM U645, University of Franche Comté, EFS Bourgogne Franche Comté, Besançon, France
  • ,
  • Xavier Pivot

      Affiliations

    • INSERM U645, University of Franche Comté, EFS Bourgogne Franche Comté, Besançon, France
    • Department of Medical Oncology, CHU Jean Minjoz, Besançon, France
  • ,
  • Pierre Tiberghien

      Affiliations

    • INSERM U645, University of Franche Comté, EFS Bourgogne Franche Comté, Besançon, France
  • ,
  • Philippe Saas

      Affiliations

    • INSERM U645, University of Franche Comté, EFS Bourgogne Franche Comté, Besançon, France
  • ,
  • Christophe Borg

      Affiliations

    • INSERM U645, University of Franche Comté, EFS Bourgogne Franche Comté, Besançon, France
    • Department of Medical Oncology, CHU Jean Minjoz, Besançon, France
    • Corresponding Author InformationOffprint requests to: Christophe Borg, M.D., Ph.D., INSERM U645, EFS Bourgogne Franche Comté, 2 Bd Fleming, 25020 Besançon, France

Received 15 August 2006; received in revised form 6 December 2006; accepted 11 December 2006.

Objective

CD4+CD25+ regulatory T lymphocytes (Treg) have been initially shown to prevent organ-specific autoimmunity. It is now accepted that Treg homeostasis depends in part on the peripheral conversion of naïve CD4+CD25 T cells. This conversion implicates acquisition of the Treg-specific markers, forkhead winged helix protein 3 (Foxp3), after CD28 costimulation. Because natural killer cells (NK) are critical for efficient cytotoxic T-cell priming and TH1 polarization, we investigated their role in Foxp3 induction in CD4+ T lymphocytes.

Materials and Methods

Human CD4+CD25 T lymphocytes were activated in vitro by CD28 costimulation in the presence of interleukin-2–activated NK. Three days after initial activation, Foxp3 protein and RNA expression were determined by flow cytometry and reverse transcription polymerase chain reaction. In vivo influence of activated NK on Foxp3 expression was studied in an adoptive transfer model of CD45.2+ CD4+CD25 lymphocytes into CD45.1+ mice.

Results

Interleukin-2–activated NK decreased Treg conversion of adoptively transferred murine CD4+CD25 T cells in vivo. Likewise, human-activated NK, but not resting NK, decreased CD28-driven Foxp3 expression in CD4+CD25 T lymphocytes, while at the same time increasing proliferation and interferon-γ (IFN-γ) production. Neutralization of IFN-γ partially restored Treg conversion and prevented TH1 polarization after CD28 costimulation.

Conclusion

The current study suggests that activated NK interfere with CD28-mediated Foxp3 expression in CD4+CD25 T lymphocytes. Our experiments further underline a molecular interaction between IFN-γ and Foxp3 downstream of CD28 signaling. Together, these results demonstrate that activated NK play a critical role at the initiation step of immune responses by modulating peripheral Treg differentiation.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0301-472X(06)00747-8

doi:10.1016/j.exphem.2006.12.004

Experimental Hematology
Volume 35, Issue 3 , Pages 416-425, March 2007